منابع مشابه
ITC 2008 Highlights
&THE 2008 INTERNATIONAL Test Conference will be held in Santa Clara, California on 28-30 October. As the premier conference for test technology, ITC continues its well-established format for Test Week (26-31 October) with two days of tutorials and a threeday conference program, followed by two days of workshops. There will be 17 tutorials this year, covering a wide range of topics. They include...
متن کاملRecent advances in vascular biology: selected highlights from IVBM 2008.
Thromb Haemost 2009; 101: 997–998 The contributions encapsulated in this themed issue of Thrombosis and Haemostasis derive from invited lectures at the 15th International Vascular Biology Meeting (IVBM) held in June, 2008 in Sydney, Australia. IVBMs, which are held every two years, have become the most prestigious international biomedical conference in blood vessel biology and disease. The scie...
متن کامل1741Emergence of Shigellosis in Males ≥13 Years — Philadelphia, 2008–2013
Background. In recent years in Philadelphia, shigellosis has shifted from a disease primarily affecting children and women of childbearing age to one that more commonly affects males ≥13 years of age. Studies of similar shifts in other U.S. cities have concluded that increased incidence among adult males may result from outbreaks among men who have sex with men (MSM). Antibiotic resistance amon...
متن کاملHighlights of 2008 in bone marrow biopsy pathology
The fiftieth anniversary of Blood saw the publication of a series of excellent review articles. The myeloproliferative disorders [1] were first characterised by Gustav Heuck who described myelofibrosis (MF) in 1879. Louis Henri Vaquez described polycythemia vera (PV) in 1892. Essential thrombocythemia (ET) followed somewhat later in 1934 when Emil Epstein and Alfred Goedel recognised it as a di...
متن کاملHighlights of the 2008 International Conference on Malignant Lymphoma.
1. Xagrid Summary of Product Characteristics, July 2014 2. Hong Y et al. Platelets. 2002 3. Petrides et al. Expert Opin Pharmacother 2004 4. Barosi G, Leukemia. 2007 Feb;21(2):277–80 Non-cytotoxic activity that allows long-term clinical use: no known mutagenic, clastogenic or leukemogenic properties1-3 If, with first-line HU: • The patient does not achieve an adequate response: if the platelet ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Stem Cell
سال: 2008
ISSN: 1934-5909
DOI: 10.1016/j.stem.2008.08.015